BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17331237)

  • 21. Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults.
    Machmutow K; Meister R; Jansen A; Kriston L; Watzke B; Härter MC; Liebherz S
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012855. PubMed ID: 31106850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The second Symptom Management Research Trial in Oncology (SMaRT Oncology-2): a randomised trial to determine the effectiveness and cost-effectiveness of adding a complex intervention for major depressive disorder to usual care for cancer patients.
    Walker J; Cassidy J; Sharpe M;
    Trials; 2009 Mar; 10():18. PubMed ID: 19331675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a multicomponent programme for the management of musculoskeletal pain and depression in primary care: a cluster-randomised clinical trial (the DROP study).
    Aragonès E; López-Cortacans G; Caballero A; Piñol JL; Sánchez-Rodríguez E; Rambla C; Tomé-Pires C; Miró J
    BMC Psychiatry; 2016 Mar; 16():69. PubMed ID: 27236335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression care management for late-life depression in China primary care: protocol for a randomized controlled trial.
    Chen S; Conwell Y; Xu B; Chiu H; Tu X; Ma Y
    Trials; 2011 May; 12():121. PubMed ID: 21569445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.
    Cox GR; Callahan P; Churchill R; Hunot V; Merry SN; Parker AG; Hetrick SE
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008324. PubMed ID: 25433518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: follow-up of the CoBalT randomised controlled trial.
    Wiles NJ; Thomas L; Turner N; Garfield K; Kounali D; Campbell J; Kessler D; Kuyken W; Lewis G; Morrison J; Williams C; Peters TJ; Hollinghurst S
    Lancet Psychiatry; 2016 Feb; 3(2):137-44. PubMed ID: 26777773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychological therapies for treatment-resistant depression in adults.
    Ijaz S; Davies P; Williams CJ; Kessler D; Lewis G; Wiles N
    Cochrane Database Syst Rev; 2018 May; 5(5):CD010558. PubMed ID: 29761488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of blended depression treatment for adults in specialised mental healthcare: study protocol for a randomised controlled trial.
    Kemmeren LL; van Schaik DJ; Riper H; Kleiboer AM; Bosmans JE; Smit JH
    BMC Psychiatry; 2016 Apr; 16():113. PubMed ID: 27102812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study).
    Rubio-Valera M; Beneitez I; Peñarrubia-María MT; Luciano JV; Mendive JM; McCrone P; Knapp M; Sabés-Figuera R; Kocyan K; García-Campayo J; Serrano-Blanco A
    BMC Psychiatry; 2015 Mar; 15():63. PubMed ID: 25885818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care.
    Saya S; Chondros P; Abela A; Mihalopolous C; Chatterton ML; Gunn J; Chen TF; Polasek TM; Dettmann E; Brooks R; King M; Spencer L; Alphonse P; Milton S; Ramsay G; Siviour Z; Liew J; Ly P; Thoenig M; Seychell R; La Rocca F; Hesson LB; Mejias N; Sivertsen T; Galea MA; Bousman C; Emery J
    Trials; 2023 May; 24(1):342. PubMed ID: 37208772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression.
    Trivedi MH; Lin EH; Katon WJ
    CNS Spectr; 2007 Aug; 12(8 Suppl 13):1-27. PubMed ID: 17986951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Collaborative care for sick-listed workers with major depressive disorder: a randomised controlled trial from the Netherlands Depression Initiative aimed at return to work and depressive symptoms.
    Vlasveld MC; van der Feltz-Cornelis CM; Adèr HJ; Anema JR; Hoedeman R; van Mechelen W; Beekman AT
    Occup Environ Med; 2013 Apr; 70(4):223-30. PubMed ID: 23112266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost effectiveness of a pharmacy-based coaching programme to improve adherence to antidepressants.
    Bosmans JE; Brook OH; van Hout HP; de Bruijne MC; Nieuwenhuyse H; Bouter LM; Stalman WA; van Tulder MW
    Pharmacoeconomics; 2007; 25(1):25-37. PubMed ID: 17192116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major depression: the importance of clinical characteristics and treatment response to prognosis.
    Katon W; Unützer J; Russo J
    Depress Anxiety; 2010; 27(1):19-26. PubMed ID: 19798766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One size fits some: the impact of patient treatment attitudes on the cost-effectiveness of a depression primary-care intervention.
    Pyne JM; Rost KM; Farahati F; Tripathi SP; Smith J; Williams DK; Fortney J; Coyne JC
    Psychol Med; 2005 Jun; 35(6):839-54. PubMed ID: 15997604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of persistence of comorbid generalized anxiety disorder among veterans with major depressive disorder.
    Mittal D; Fortney JC; Pyne JM; Wetherell JL
    J Clin Psychiatry; 2011 Nov; 72(11):1445-51. PubMed ID: 21208594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care.
    Mynors-Wallis LM; Gath DH; Day A; Baker F
    BMJ; 2000 Jan; 320(7226):26-30. PubMed ID: 10617523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost utility analysis of a collaborative stepped care intervention for panic and generalized anxiety disorders in primary care.
    Goorden M; Muntingh A; van Marwijk H; Spinhoven P; Adèr H; van Balkom A; van der Feltz-Cornelis C; Hakkaart-van Roijen L
    J Psychosom Res; 2014 Jul; 77(1):57-63. PubMed ID: 24913343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.